Wed Apr 21, 2021 22:35
English | 繁體 | 简体
LIVZON PHARMA (1513)
Year: 2021|2020 |2019 |2018 |2017 |2016 |2015
18:11
2021 FIRST QUARTERLY REPORT
15 Apr 2021
Overseas Regulatory Announcement
15 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
15 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
15 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
15 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
15 Apr 2021
PROPOSED COMPANY''S PROVISION OF FINANCING GUARANTEES TO CONTROLLING SUBSIDIARY LIVZON MAB
15 Apr 2021
NOTICE OF THE 2021 FIRST CLASS MEETING OF H SHAREHOLDERS
15 Apr 2021
NOTICE OF THE ANNUAL GENERAL MEETING FOR THE YEAR 2020
09 Apr 2021
CONNECTED TRANSACTION IN RELATION TO GRANT OF SUBSCRIPTION TO CONNECTED PERSONS PURSUANT TO THE PROPOSED FIRST PHASE OWNERSHIP SCHEME
08 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 Apr 2021
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
08 Apr 2021
NOTICE OF THE 2021 SECOND EXTRAORDINARY GENERAL MEETING
07 Apr 2021
Overseas Regulatory Announcement
06 Apr 2021
VOLUNTARY ANNOUNCEMENT UPDATE ON ACQUISITION OF 40.00% EQUITY INTEREST IN TIANJIN TONGRENTANG
01 Apr 2021
ANNOUNCEMENT ON PROGRESS OF REPURCHASE OF H SHARES
Next >  
Quote
HSI: 28,621.92 -513.81
33.55
0.25 (0.8%)
As of16:10 21 Apr 2021
Open: 33.15 52Wk High: 42.60
Day High: 34.05 52Wk Low: 26.80
Day Low: 33.15 P/E: 15.432
Prev. Close: 33.30 Yield: 4.422%
Volume: 405.16K
Mkt Cap: 10.65B
Turnover: 13.64M NAV: 15.208
Quotes are delayed by at least 15 minutes.
Contact LIVZON PHARMA
Company Address:
Room 1301, 13th Floor, China Evergrande Centre, 38 Gloucester Road, Wanchai, Hong Kong
Web: http://www.livzon.com.cn

To request additional information on this company, please complete the form below and we will contact the company on your behalf.

Name:*
Company:
Position:
Phone:
E-mail:*
Existing Shareholder: Yes No
Message:*  

* Required Fields
A founding member of:
China Tonghai IR:
Sitemap  |  About Us  |  Contact Us  |  Disclaimers     English | 繁體 | 简体  
Tonghai Financial:
China Tonghai International Financial Limited  |  China Tonghai Capital  |  China Tonghai Securities
Oceanwide Financial Management   |  Quamnet
 
Information of TonghaiIR (Investor Relations):
[Hong Kong Listed Company Information] [Financial News] [Announcement Alerts] [Free Delayed Stock Quote] [Chart]
[Hong Kong stock information]

TonghaiIR (Investor Relations) Services:
[Listed Companies Information] [Listed Companies Financial Information] [Listed Companies Announcements]
[Listed Companies Circulars] [Listed Companies News] [Press Releases] [Listed Companies Event Calendar]
[Listed Companies Presentations] [Proxy Forms]

China Tonghai IR (Investor Relations):
[Securities Firms] [Fund Houses] [Venture Capitals] [Financial Public Relations Agencies] [Financial Printers]
Investor Relations Dictionary:
[Listed Companies Result Announcement] [Financial Report] [Interim Report] [Annual General Meeting]
[Extraordinary General Meeting] [Board Meeting] [Annual Report] [Contact Listed Companies Investor Relations]
[Company Information Sheet] [Next Day Disclosure Return] [News Release] [IPO] [Prospectus] [Stock Quote] [Trading Volume]